Skip to main content
. 2020 Jan 21;13:221–229. doi: 10.2147/JPR.S216219

Table 5.

Adverse Events of Special Interest in Subjects Undergoing Orthopedic Surgery

Event Meloxicam IV (n=283) Placebo (n=96)
No. Subjects (%) No. Subjects (%)
Bleeding 13 (4.6) 4 (4.2)
Cardiovascular 3 (1.1) 2 (2.1)
Hepatic 27 (9.5) 7 (7.3)
Injection site reactions 0 0
Renal 4 (1.4) 0
Thrombotic 3 (1.1) 0
Wound healing 12 (4.2) 3 (3.1)

Abbreviation: IV, intravenous.